Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cardinal Health

Are Wall Street Analysts Bullish on Cardinal Health Stock?

As Cardinal Health has outpaced relative to the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook about the stock’s prospects.

Barchart

Levothyroxine: Thyroid medication recalled across US due to low potency

Major Pharmaceuticals is voluntarily recalling a number of Levothyroxine Sodium Tablets due to subpotency, the US Food and Drug Administration (FDA) has said. According to the government agency's Enforcement Report, the recall was initiated on July 13 and affects pills distributed by Major Pharmaceuticals and Cardinal Health. The recalled products…

The Independent UK

Three Lots of a Common Chemotherapy Drug Are Being Recalled for Steel Particles in the Vials

Three lots of cyclophosphamide injection are recalled for steel particles. No injuries reported. Here is what cancer patients can ask their care team.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has outperformed the healthcare sector over the past year. Moreover, Wall Street analysts are strongly bullish on the stock.

Barchart

Why Coca-Cola and Walmart Top This List of Steady, Low-Volatility Dividend Aristocrats

Dividend Aristocrats can offer income, stability, and consistency. Here are four lower-volatility names analysts still like.

Barchart

The 3 Dividend Aristocrats Wall Street Calls a ‘Strong Buy’ With Up to 46% Upside

These 3 Strong Buy Dividend Aristocrats have decades of payout growth, durable businesses, and analyst-backed upside of up to 46%.

Barchart

Check Your Cabinets: 170 Million Alcohol Prep Pads Recalled Over Life-Threatening Bacteria Risk

Image source: shutterstock.com

Kids Ain't Cheap

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Aristocrat Stocks Up 200% That Nobody Is Talking About

Three top-performing Dividend Aristocrats delivered big 5-year gains, steady dividend growth, and still look positioned for more upside ahead.

Barchart

Is Cardinal Health Stock Outperforming the Dow?

As Cardinal Health has outpaced the Dow over the past year, analysts remain bullish about the stock’s prospects.

Barchart

Cardinal Health Stock: Is Wall Street Bullish or Bearish?

Cardinal Health has outperformed the broader market over the past year, and analysts remain highly optimistic about the stock’s prospects.

Barchart

These Dividend Aristocrats Wildly Outperformed the S&P 500

Discover these 3 Dividend Aristocrats that have outperformed the S&P 500 by a wide margin.

Barchart

Is Cardinal Health Stock Outperforming the Nasdaq?

Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.

Barchart

6 Healthcare Stocks With Strong Upward Momentum

Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.

Benzinga

Marjorie Taylor Greene Already Made Double-Digit Gains From Amazon; Cardinal Health Trades Days Before Earnings Beat

Greene's investments in Amazon and Cardinal Health on 24 October are up 11.5% and 21.5%, respectively, following the companies' strong Q3 earnings reports.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Cardinal Health Stock: Analyst Estimates & Ratings

Cardinal Health has experienced robust growth in earnings and topline recently. Observing the momentum, analysts remain strongly bullish on the stock’s prospects.

Benzinga

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Thursday.

Barchart

3 Dividend Aristocrats Up 20%+ YTD With More Upside Ahead

These 3 buy-rated Dividend Aristocrats are up 20%+ YTD, and offer reliable dividends with more growth potential ahead.

Barchart

Is Cardinal Health Stock Underperforming the S&P 500?

While Cardinal Health has considerably underperformed the S&P 500 recently, analysts remain highly optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Dividend Aristocrats on Sale: Oversold, High Quality, and Built to Last

Three oversold Dividend Aristocrats rated ‘Buy’ by Wall Street—rare bargains offering income, stability, and rebound potential.

Benzinga

Cardinal Health Boosts Specialty Presence With Solaris Health Acquisition, Lifts Profit Outlook

Cardinal Health Inc. (NYSE:CAH) shares fell Tuesday after the company reported mixed fourth-quarter results and announced a $1.9 billion deal to acquire Solaris Health.

Barchart

Inflation Report: Consumer Prices Up 2.7% Annually, Meeting Expectations

September S&P 500 E-Mini futures (ESU25) are up +0.06%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.02% this morning as investors refrained from making big bets ahead of key U.S. inflation data that could reshape expectations for Federal Reserve rate cuts.

Benzinga

Cardinal Health, Ziprecruiter And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Benzinga

Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.

Benzinga

How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.

Barchart

Do Wall Street Analysts Like Cardinal Health Stock?

Cardinal Health has outperformed the broader market over the past year, and analysts maintain a strongly bullish outlook on its future prospects.

1 2 3 4

People

Marjorie Taylor Greene

3,116 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.